
Michael DiGiovanna, M.D., Ph.D.
Yale University Cancer Center
Awarded $33,000
Co-Targeting IGF-1 Receptor and HER3 in Breast Cancer
CELEBRATING IMPACT AND PROGRESS LOCALLY IN THE FIGHT AGAINST BREAST CANCER
Yale University Cancer Center
Awarded $33,000
Co-Targeting IGF-1 Receptor and HER3 in Breast Cancer
UConn Health Center
Awarded $50,000
Identification of a new anti-breast cancer drug, SAM
UConn Health Center
Awarded $42,000
Therapeutic Targeting of Breast Cancer Stem Cells
UConn Health Center
Awarded $40,000
Vascular and Proliferation – Dependent Protein Expression in Breast Cancer Samples as a way to distinguish HER2 Positive from HER2 Negative Tumors